Cart
sales@molnova.com
(S)-BRS-3 agonist Compound A
CAS No. ——
(S)-BRS-3 agonist Compound A( —— )
Catalog No. M17038 CAS No. ——
The distomer of BRS-3 agonist Compound A, shows no activity for bombesin receptor subtype-3 (BRS-3) with EC50>10 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name(S)-BRS-3 agonist Compound A
-
NoteResearch use only, not for human use.
-
Brief DescriptionThe distomer of BRS-3 agonist Compound A, shows no activity for bombesin receptor subtype-3 (BRS-3) with EC50>10 uM.
-
DescriptionThe distomer of BRS-3 agonist Compound A, shows no activity for bombesin receptor subtype-3 (BRS-3) with EC50>10 uM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetBombesin Receptor
-
RecptorBombesin Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight428.532
-
Molecular FormulaC27H28N2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameS-6-benzyl-N-tert-butyl-9-methoxy-7-oxo-6,7-dihydro-5H-dibenzo[c,e]azepine-5-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Nio Y, et al. Endocrinology. 2017 May 1;158(5):1298-1313.
molnova catalog
related products
-
BRS-3 agonist Compou...
A potent, selective, orally active bombesin receptor subtype-3 (BRS-3) agonist.
-
CD80-IN-3
CD80-IN-3 is a potent CD80 inhibitor and inhibits CD80/CD28 interaction (Kd: 125 nM; EC50: 630 nM).
-
PD176252
PD176252 is a potent BB1 and BB2 antagonist with inhibitory effects on BB1 and BB2 receptors.PD176252 acts as a small molecule GRPR inhibitor and FPR1/FPR2 agonist to inhibit the growth and proliferation of a variety of cancer cells.
